organic compounds\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890

6-Fluoro-4-oxochroman-2-carboxylic acid

aKey Laboratory of Drug Targeting of the Education Ministry, West China School of Pharmacy, Sichuan University, Chengdu 610041, People's Republic of China
*Correspondence e-mail: wyong@scu.edu.cn

(Received 12 December 2009; accepted 18 December 2009; online 9 January 2010)

The title compound, C10H7FO4, is an inter­mediate in the synthesis of the drug Fidarestat, (2S,4S)-2-aminoformyl-6-fluoro-spiro[chroman-4,4′-imidazolidine]-2′,5′-dione. The di­hydro­pyran­one ring adopts an envelope conformation with the asymmetric C atom in the flap position. In the crystal, the mol­ecules are linked into zigzag chains along [100] by O—H⋯O hydrogen bonds and C—H⋯π inter­actions involving the benzene ring.

Related literature

Fidarestat, which shows strong inhibition to aldose reducta­ses, is used to treat complications of diabetes, see: Mealy (1996[Mealy, N. (1996). Drugs Future, 21, 261-265.]); Mitsuru et al. (2000[Mitsuru, O., Yudiharu, M., Shigeru, S., Oka, M., Matsumoto, Y., Sugiyama, S., Tsuruta, N. & Matsushima, M. (2000). J. Med. Chem. 43, 2479-2483.]). For related structures, see: Kurono et al. (1989[Kurono, M., Kondo, Y., Yamaguchi, T., Miura, K., Usui, T., Terada, N., Asano, K., Mizuno, K., Matsubara, A., Kato, N., Sawai, K., Unno, T., Ozawa, H. & Fukushima, M. (1989). US Patent No. 4861792.]); Yamaguchi et al. (1994[Yamaguchi, T., Miura, K., Usui, T., Unno, R., Matsumoto, Y., Fukushima, M., Mizuno, K., Kondo, Y., Baba, Y. & Kurono, M. (1994). Arzneim. Forsch. 44, 344-348.]).

[Scheme 1]

Experimental

Crystal data
  • C10H7FO4

  • Mr = 210.16

  • Orthorhombic, P 21 21 21

  • a = 5.3472 (11) Å

  • b = 12.748 (3) Å

  • c = 12.785 (3) Å

  • V = 871.5 (3) Å3

  • Z = 4

  • Mo Kα radiation

  • μ = 0.14 mm−1

  • T = 113 K

  • 0.28 × 0.23 × 0.22 mm

Data collection
  • Rigaku Saturn CCD area-detector diffractometer

  • Absorption correction: multi-scan (ABSCOR; Higashi, 1995[Higashi, T. (1995). ABSCOR. Rigaku Corperation, Tokyo, Japan.]) Tmin = 0.962, Tmax = 0.970

  • 8640 measured reflections

  • 1212 independent reflections

  • 1049 reflections with I > 2σ(I)

  • Rint = 0.045

Refinement
  • R[F2 > 2σ(F2)] = 0.027

  • wR(F2) = 0.073

  • S = 1.12

  • 1212 reflections

  • 137 parameters

  • H-atom parameters constrained

  • Δρmax = 0.17 e Å−3

  • Δρmin = −0.15 e Å−3

Table 1
Hydrogen-bond geometry (Å, °)

D—H⋯A D—H H⋯A DA D—H⋯A
O4—H4⋯O2i 0.84 1.81 2.6474 (19) 171
C5—H5BCg1ii 0.99 2.51 3.4521 (19) 160
Symmetry codes: (i) [x+{\script{1\over 2}}, -y+{\script{1\over 2}}, -z]; (ii) x-1, y, z. Cg1 is the centroid of the C1–C3/C7–C9 ring.

Data collection: CrystalClear (Rigaku/MSC, 2005[Rigaku/MSC (2005). CrystalClear. Rigaku/MSC, The Woodlands, Texas, USA.]); cell refinement: CrystalClear; data reduction: CrystalClear; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: ORTEP-3 (Farrugia, 1997[Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.]); software used to prepare material for publication: SHELXL97.

Supporting information


Comment top

The optically active (S)-6-fluoro-4-oxochroman-2-carboxylic acid is a key intermediate for synthesizing Fidarestat which shows strong inhibition to aldose reductases to cure incurable complications of diabetes (Mitsuru et al., 2000; Mealy, 1996). Our interests in synthesizing Fidarestat prompted us to develop an efficient methodology for synthesizing (S)-6-fluoro-4-oxochroman-2-carboxylic acid. In our synthetic work, we obtained the title compound, which is similar to those reported in the literature (Kurono et al., 1989; Yamaguchi et al., 1994). Its crystal structure is reported here.

The dihydropyranone ring adopts an envelope conformation with the asymmetric C atom in the flap position (Fig. 1). The molecules are linked into zigzag chains along the [100] by O—H···O hydrogen bonds and C—H···π interactions (Table 1) involving the benzene ring.

Related literature top

Fidarestat, which shows strong inhibition to aldose reductases, is used to treat complications of diabetes, see: Mealy (1996); Mitsuru et al. (2000). For related structures, see: Kurono et al. (1989); Yamaguchi et al. (1994).

Experimental top

To a stirred solution of (2S,4R)-2-(1',2'-Dihydroxyethyl)-6-fluoro-chroman-4-one (10.7 g, 0.05 mol) in 300 ml of anhydrous benzene at room temperature was added lead tetraacetate (22.2 g, 0.05 mol). After 30 min, the solution was filtered and the filtrate was evaporated in vacuum to the residue. To the solution of 2% aqueous silver nitrate (651 ml, 0.07 mol) was added 5% aqueous sodium hydroxide (120 ml, 0.16 mol), and then generated the black precipitate immediately. To this stirred solution at room temperature was added, dropwise over 5 min, 4% ammonia water (520 ml, 0.16 mol). The black precipitate disappeared. The residue described above was dissolved in small amounts of THF and then added in this stirred solution at 323–333 K. After 10 min, the solution was filtered, and the precipitate was washed with water. The filtrate was acidified to pH 1 with 6 N aqueous hydrochloric acid, and then extracted with ethyl acetate. The organic extracts were dried (MgSO4) and then concentrated under reduced pressure. The residue was mixed with a mixture of ethanol and water, and left to crystallize 8.7 g (83%) of 6-Fluoro- 4-oxochroman-2-carboxylic acid. Colourless crystals suitable for X-ray analysis were obtained by slow evaporation in ethanol at room temperature.

Refinement top

H atoms were positioned geometrically (O-H = 0.84 and C-H = 0.95–1.00 Å) and refined using a riding model, with Uiso(H) = 1.2Ueq(C) and 1.5Ueq(O). In the absence of significant anomalous scattering, Friedel pairs were merged prior to the final refinement. Nine reflections that were affected by the beamstop were discarded.

Structure description top

The optically active (S)-6-fluoro-4-oxochroman-2-carboxylic acid is a key intermediate for synthesizing Fidarestat which shows strong inhibition to aldose reductases to cure incurable complications of diabetes (Mitsuru et al., 2000; Mealy, 1996). Our interests in synthesizing Fidarestat prompted us to develop an efficient methodology for synthesizing (S)-6-fluoro-4-oxochroman-2-carboxylic acid. In our synthetic work, we obtained the title compound, which is similar to those reported in the literature (Kurono et al., 1989; Yamaguchi et al., 1994). Its crystal structure is reported here.

The dihydropyranone ring adopts an envelope conformation with the asymmetric C atom in the flap position (Fig. 1). The molecules are linked into zigzag chains along the [100] by O—H···O hydrogen bonds and C—H···π interactions (Table 1) involving the benzene ring.

Fidarestat, which shows strong inhibition to aldose reductases, is used to treat complications of diabetes, see: Mealy (1996); Mitsuru et al. (2000). For related structures, see: Kurono et al. (1989); Yamaguchi et al. (1994).

Computing details top

Data collection: CrystalClear (Rigaku/MSC, 2005); cell refinement: CrystalClear (Rigaku/MSC, 2005); data reduction: CrystalClear (Rigaku/MSC, 2005); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 1997); software used to prepare material for publication: SHELXL97 (Sheldrick, 2008).

Figures top
[Figure 1] Fig. 1. The molecular structure of the title compound, with displacement ellipsoids drawn at the 50% probability level.
6-Fluoro-4-oxochroman-2-carboxylic acid top
Crystal data top
C10H7FO4F(000) = 432
Mr = 210.16Dx = 1.602 Mg m3
Orthorhombic, P212121Mo Kα radiation, λ = 0.71073 Å
Hall symbol: P 2ac 2abCell parameters from 3184 reflections
a = 5.3472 (11) Åθ = 1.6–27.8°
b = 12.748 (3) ŵ = 0.14 mm1
c = 12.785 (3) ÅT = 113 K
V = 871.5 (3) Å3Block, colourless
Z = 40.28 × 0.23 × 0.22 mm
Data collection top
Rigaku Saturn CCD area-detector
diffractometer
1212 independent reflections
Radiation source: rotating anode1049 reflections with I > 2σ(I)
Confocal monochromatorRint = 0.045
Detector resolution: 7.31 pixels mm-1θmax = 27.9°, θmin = 2.3°
ω and φ scansh = 76
Absorption correction: multi-scan
(ABSCOR; Higashi, 1995)
k = 1616
Tmin = 0.962, Tmax = 0.970l = 1616
8640 measured reflections
Refinement top
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.027Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.073H-atom parameters constrained
S = 1.12 w = 1/[σ2(Fo2) + (0.0448P)2]
where P = (Fo2 + 2Fc2)/3
1212 reflections(Δ/σ)max = 0.001
137 parametersΔρmax = 0.17 e Å3
0 restraintsΔρmin = 0.15 e Å3
Crystal data top
C10H7FO4V = 871.5 (3) Å3
Mr = 210.16Z = 4
Orthorhombic, P212121Mo Kα radiation
a = 5.3472 (11) ŵ = 0.14 mm1
b = 12.748 (3) ÅT = 113 K
c = 12.785 (3) Å0.28 × 0.23 × 0.22 mm
Data collection top
Rigaku Saturn CCD area-detector
diffractometer
1212 independent reflections
Absorption correction: multi-scan
(ABSCOR; Higashi, 1995)
1049 reflections with I > 2σ(I)
Tmin = 0.962, Tmax = 0.970Rint = 0.045
8640 measured reflections
Refinement top
R[F2 > 2σ(F2)] = 0.0270 restraints
wR(F2) = 0.073H-atom parameters constrained
S = 1.12Δρmax = 0.17 e Å3
1212 reflectionsΔρmin = 0.15 e Å3
137 parameters
Special details top

Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.

Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) top
xyzUiso*/Ueq
F10.8260 (2)0.32440 (8)0.43315 (9)0.0336 (3)
O10.2480 (2)0.03466 (8)0.23160 (9)0.0189 (3)
O20.1188 (2)0.34646 (9)0.17373 (10)0.0230 (3)
O30.5538 (2)0.03536 (10)0.06321 (10)0.0230 (3)
O40.2609 (3)0.11076 (10)0.03716 (9)0.0250 (3)
H40.37990.11790.07950.037*
C10.6806 (3)0.25426 (12)0.38164 (13)0.0200 (4)
C20.5057 (3)0.29048 (13)0.31336 (12)0.0184 (4)
H20.48620.36360.30150.022*
C30.3547 (3)0.21751 (12)0.26079 (12)0.0152 (3)
C40.1561 (3)0.25266 (12)0.19024 (12)0.0154 (3)
C50.0026 (3)0.16808 (13)0.14292 (12)0.0175 (3)
H5A0.05880.19050.07260.021*
H5B0.15290.15730.18680.021*
C60.1404 (3)0.06506 (12)0.13377 (12)0.0167 (3)
H60.01820.00950.11300.020*
C70.3894 (3)0.10981 (12)0.27966 (12)0.0155 (4)
C80.5700 (3)0.07625 (13)0.35030 (12)0.0182 (4)
H80.59230.00340.36300.022*
C90.7161 (4)0.14813 (12)0.40169 (12)0.0200 (4)
H90.83960.12570.45020.024*
C100.3450 (3)0.06823 (12)0.05065 (13)0.0174 (3)
Atomic displacement parameters (Å2) top
U11U22U33U12U13U23
F10.0418 (7)0.0231 (5)0.0358 (6)0.0017 (5)0.0248 (5)0.0041 (5)
O10.0218 (6)0.0139 (5)0.0211 (5)0.0031 (5)0.0003 (5)0.0013 (4)
O20.0246 (7)0.0158 (6)0.0287 (6)0.0020 (5)0.0091 (5)0.0024 (5)
O30.0155 (6)0.0265 (6)0.0270 (6)0.0037 (5)0.0012 (5)0.0053 (5)
O40.0189 (6)0.0340 (6)0.0221 (6)0.0007 (6)0.0050 (6)0.0024 (5)
C10.0225 (10)0.0191 (8)0.0184 (7)0.0018 (7)0.0048 (7)0.0029 (7)
C20.0226 (10)0.0146 (7)0.0181 (7)0.0007 (7)0.0026 (7)0.0004 (6)
C30.0155 (8)0.0147 (7)0.0155 (7)0.0006 (6)0.0004 (6)0.0009 (6)
C40.0137 (8)0.0165 (8)0.0161 (7)0.0007 (7)0.0018 (6)0.0007 (6)
C50.0142 (8)0.0182 (8)0.0201 (8)0.0016 (7)0.0011 (6)0.0024 (6)
C60.0151 (8)0.0149 (7)0.0201 (8)0.0027 (7)0.0004 (6)0.0013 (6)
C70.0170 (9)0.0140 (7)0.0154 (7)0.0006 (7)0.0045 (7)0.0012 (6)
C80.0226 (9)0.0137 (7)0.0181 (7)0.0049 (7)0.0033 (7)0.0035 (6)
C90.0217 (9)0.0229 (8)0.0154 (7)0.0042 (7)0.0006 (7)0.0024 (6)
C100.0174 (9)0.0133 (7)0.0214 (8)0.0041 (7)0.0010 (7)0.0048 (7)
Geometric parameters (Å, º) top
F1—C11.3557 (18)C3—C41.464 (2)
O1—C71.366 (2)C4—C51.499 (2)
O1—C61.4302 (19)C5—C61.524 (2)
O2—C41.2305 (19)C5—H5A0.99
O3—C101.203 (2)C5—H5B0.99
O4—C101.325 (2)C6—C101.526 (2)
O4—H40.84C6—H61.00
C1—C21.360 (2)C7—C81.390 (2)
C1—C91.390 (2)C8—C91.372 (2)
C2—C31.403 (2)C8—H80.95
C2—H20.95C9—H90.95
C3—C71.406 (2)
C7—O1—C6115.20 (12)H5A—C5—H5B108.0
C10—O4—H4109.5O1—C6—C5111.60 (12)
F1—C1—C2118.84 (14)O1—C6—C10109.14 (14)
F1—C1—C9118.29 (15)C5—C6—C10112.98 (13)
C2—C1—C9122.87 (16)O1—C6—H6107.6
C1—C2—C3118.56 (15)C5—C6—H6107.6
C1—C2—H2120.7C10—C6—H6107.6
C3—C2—H2120.7O1—C7—C8117.44 (14)
C2—C3—C7119.28 (15)O1—C7—C3122.30 (15)
C2—C3—C4120.64 (14)C8—C7—C3120.25 (15)
C7—C3—C4120.03 (14)C9—C8—C7120.09 (15)
O2—C4—C3121.39 (14)C9—C8—H8120.0
O2—C4—C5122.54 (15)C7—C8—H8120.0
C3—C4—C5116.04 (13)C8—C9—C1118.95 (16)
C4—C5—C6111.51 (13)C8—C9—H9120.5
C4—C5—H5A109.3C1—C9—H9120.5
C6—C5—H5A109.3O3—C10—O4124.77 (16)
C4—C5—H5B109.3O3—C10—C6124.27 (15)
C6—C5—H5B109.3O4—C10—C6110.96 (14)
F1—C1—C2—C3179.60 (15)C6—O1—C7—C324.6 (2)
C9—C1—C2—C30.1 (3)C2—C3—C7—O1179.64 (14)
C1—C2—C3—C70.4 (2)C4—C3—C7—O12.1 (2)
C1—C2—C3—C4177.15 (14)C2—C3—C7—C80.5 (2)
C2—C3—C4—O21.2 (2)C4—C3—C7—C8177.00 (14)
C7—C3—C4—O2178.73 (16)O1—C7—C8—C9179.41 (14)
C2—C3—C4—C5176.75 (14)C3—C7—C8—C90.3 (2)
C7—C3—C4—C50.8 (2)C7—C8—C9—C10.2 (2)
O2—C4—C5—C6154.54 (16)F1—C1—C9—C8179.88 (15)
C3—C4—C5—C627.50 (19)C2—C1—C9—C80.3 (3)
C7—O1—C6—C552.00 (18)O1—C6—C10—O310.0 (2)
C7—O1—C6—C1073.59 (16)C5—C6—C10—O3134.74 (16)
C4—C5—C6—O153.01 (17)O1—C6—C10—O4170.78 (12)
C4—C5—C6—C1070.43 (17)C5—C6—C10—O446.00 (17)
C6—O1—C7—C8156.25 (14)
Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
O4—H4···O2i0.841.812.6474 (19)171
C5—H5B···Cg1ii0.992.513.4521 (19)160
Symmetry codes: (i) x+1/2, y+1/2, z; (ii) x1, y, z.

Experimental details

Crystal data
Chemical formulaC10H7FO4
Mr210.16
Crystal system, space groupOrthorhombic, P212121
Temperature (K)113
a, b, c (Å)5.3472 (11), 12.748 (3), 12.785 (3)
V3)871.5 (3)
Z4
Radiation typeMo Kα
µ (mm1)0.14
Crystal size (mm)0.28 × 0.23 × 0.22
Data collection
DiffractometerRigaku Saturn CCD area-detector
Absorption correctionMulti-scan
(ABSCOR; Higashi, 1995)
Tmin, Tmax0.962, 0.970
No. of measured, independent and
observed [I > 2σ(I)] reflections
8640, 1212, 1049
Rint0.045
(sin θ/λ)max1)0.657
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.027, 0.073, 1.12
No. of reflections1212
No. of parameters137
H-atom treatmentH-atom parameters constrained
Δρmax, Δρmin (e Å3)0.17, 0.15

Computer programs: CrystalClear (Rigaku/MSC, 2005), SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), ORTEP-3 (Farrugia, 1997).

Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
O4—H4···O2i0.841.812.6474 (19)171
C5—H5B···Cg1ii0.992.513.4521 (19)160
Symmetry codes: (i) x+1/2, y+1/2, z; (ii) x1, y, z.
 

References

First citationFarrugia, L. J. (1997). J. Appl. Cryst. 30, 565.  CrossRef IUCr Journals Google Scholar
First citationHigashi, T. (1995). ABSCOR. Rigaku Corperation, Tokyo, Japan.  Google Scholar
First citationKurono, M., Kondo, Y., Yamaguchi, T., Miura, K., Usui, T., Terada, N., Asano, K., Mizuno, K., Matsubara, A., Kato, N., Sawai, K., Unno, T., Ozawa, H. & Fukushima, M. (1989). US Patent No. 4861792.  Google Scholar
First citationMealy, N. (1996). Drugs Future, 21, 261–265.  CAS Google Scholar
First citationMitsuru, O., Yudiharu, M., Shigeru, S., Oka, M., Matsumoto, Y., Sugiyama, S., Tsuruta, N. & Matsushima, M. (2000). J. Med. Chem. 43, 2479–2483.  Web of Science PubMed Google Scholar
First citationRigaku/MSC (2005). CrystalClear. Rigaku/MSC, The Woodlands, Texas, USA.  Google Scholar
First citationSheldrick, G. M. (2008). Acta Cryst. A64, 112–122.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationYamaguchi, T., Miura, K., Usui, T., Unno, R., Matsumoto, Y., Fukushima, M., Mizuno, K., Kondo, Y., Baba, Y. & Kurono, M. (1994). Arzneim. Forsch. 44, 344–348.  CAS Google Scholar

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Follow Acta Cryst. E
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds